Guggenheim Issues Positive Forecast for Apogee Therapeutics (NASDAQ:APGE) Stock Price
Apogee Therapeutics (NASDAQ:APGE – Get Free Report) had its price objective increased by stock analysts at Guggenheim from $95.00 to $110.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Guggenheim’s target price would indicate a potential upside of 150.23% from the stock’s current price. A number […]
More Stories
RGM Capital LLC Sells 1,653,048 Shares of Smartsheet Inc (NYSE:SMAR)
RGM Capital LLC cut its stake in Smartsheet Inc (NYSE:SMAR – Free Report) by 74.3% in the third quarter, HoldingsChannel...
MetLife Investment Management LLC Trims Stock Position in The Charles Schwab Co. (NYSE:SCHW)
MetLife Investment Management LLC trimmed its holdings in The Charles Schwab Co. (NYSE:SCHW – Free Report) by 2.4% in the...
RPg Family Wealth Advisory LLC Buys New Holdings in Chipotle Mexican Grill, Inc. (NYSE:CMG)
RPg Family Wealth Advisory LLC purchased a new position in shares of Chipotle Mexican Grill, Inc. (NYSE:CMG – Free Report)...
RGM Capital LLC Has $135.31 Million Position in Tenable Holdings, Inc. (NASDAQ:TENB)
RGM Capital LLC reduced its stake in Tenable Holdings, Inc. (NASDAQ:TENB – Free Report) by 5.7% during the 3rd quarter,...
MetLife Investment Management LLC Cuts Stock Holdings in Caterpillar Inc. (NYSE:CAT)
MetLife Investment Management LLC reduced its stake in Caterpillar Inc. (NYSE:CAT – Free Report) by 3.3% in the third quarter,...
Healthcare of Ontario Pension Plan Trust Fund Grows Stock Holdings in Microchip Technology Incorporated (NASDAQ:MCHP)
Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of Microchip Technology Incorporated (NASDAQ:MCHP – Free Report)...